hGIPR

Nomenclature

C57BL/6Smoc-Giprtm2(hGIPR)Smoc

Cat. NO.

NM-HU-225064

Strain State

Repository Live

Export PDF

Gene Summary

Gene Symbol
Gipr

Model Description

The endogenous mouse Gipr gene was replaced by human GIPR gene.

Validation Data

image.png

Fig.1 Detection of GIPR expression in brain by RT-PCR. Brain RNA was extracted from 12-14-week-old female wild-type C57BL/6 mice (WT) and homozygous hGIPR knockin mice (HO), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mouse or human mRNA primers. Mouse Gipr mRNA (177 bp) was detectable only in wild-type C57BL/6 mice. Human GIPR mRNA (343 bp) was detectable only in homozygous hGIPR knockin mice but not in wild-type mice. 

image.png

Fig.2 Detection of GIPR protein expression in hGIPR mice by WB. The pancreas, brain, liver and brown adipocyte tissue (BAT) lysates were collected from 12-14-week-old female wild-type C57BL/6 mice and homozygous hGIPR mice, and then analyzed by western blot with anti-GIPR antibody. GIPR was obviously detectable in pancreas and liver from both WT C57BL/6 and homozygous hGIPR mice, as the antibody was cross-reactived between human and mouse GIPR. 

Abbr. M, marker; HO, homozygous; WT, wild type.

image.png

Fig. 3 In vivo function of hGIP inintraperitoneal glucose tolerance test (IPGTT). Concentration of plasma glucose were measured after intraperitoneal injection of glucose and 50 nmol/Kg human GIP in 6-8 weeks old wild-type C57BL/6 male mice and hGIPR male mice (n=6, Mean ± SEM, Student’s t test, *p<0.05, **p<0.01, ***p<0.001).


You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more